Fortis Therapeutics LLP
About Fortis Therapeutics LLP
Data last updated:
Fortis Therapeutics LLP is a limited liability partnership (LLP) based in Dibrugarh, Assam, India. It was incorporated on 03 February 2024.
The LLP is registered with the Registrar of Companies (ROC), Guwahati, under LLPIN ACF-3008.
The LLP has a total obligation of contribution of ₹60,000. It is led by designated partners Arvind Varma and Rohit Kumar Killa.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at C/O Mridu Paban Mahanta J. Das Line (Jogesh Das Path Khaliamari), Dibrugarh, Assam, India – 786001.
As per MCA filings, the LLP has open charges of ₹35 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Mridu Paban Mahanta J. Das Line (Jogesh Das Path Khaliamari), Dibrugarh, Assam, India – 786001
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Fortis Therapeutics LLP FY 2025 filings available
Financial Statement Summary of Fortis Therapeutics LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | •••• | •••• |
| Other Income | •••• | •••• |
| Total Income | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• |
| Personnel Expenses | •••• | •••• |
| Administrative Expenses | •••• | •••• |
| Interest | •••• | •••• |
| Depreciation | •••• | •••• |
| Total Expenses | •••• | •••• |
| Profit Before Tax | •••• | •••• |
| Tax | •••• | •••• |
| Profit After Tax | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• |
| Assets and Liabilities | ||
| Partners' Contribution | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Secured Loans | •••• | •••• |
| Unsecured Loans | •••• | •••• |
| Trade Payables | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Loans and Advances | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Fortis Therapeutics LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | •••• | •••• |
| Return on Partners' Funds | •••• | •••• |
| Return on Assets | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• |
| Interest Coverage | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Turnover Growth | •••• | •••• |
| Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Fortis Therapeutics are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Fortis Therapeutics LLP
Fortis Therapeutics has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Varma Also directs: Jorbagh Tea LLP, Jorbagh Tea Private Limited, Dibrugarh Beverages and Aqua Private Limited and 2 more | Designated Partner | 08 May 2025 | 1 Years 5 Months | Current |
| Rohit Kumar Killa | Designated Partner | 03 Feb 2024 | 2 Years 8 Months | Current |
Charges & Borrowings of Fortis Therapeutics LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2025 | Canara Bank | ₹35 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Fortis Therapeutics LLP
Employment history and EPFO contributions of people linked to Fortis Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fortis Therapeutics LLP
Fortis Therapeutics LLP has 3 designated partner changes on record since 2024: 2 appointments and 1 cessation. The latest: Arvind Varma was appointed as Designated Partner on 08 May 2025.
Credit Ratings, Litigation & Regulatory Alerts for Fortis Therapeutics LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fortis Therapeutics LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fortis Therapeutics LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fortis Therapeutics LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fortis Therapeutics LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fortis Therapeutics LLP
Fortis Therapeutics is an active limited liability partnership based in Dibrugarh, Assam, India. It was incorporated on 03 February 2024 (2+ years old) and is registered under LLPIN ACF-3008.
Fortis Therapeutics has 2 current designated partners:
- Arvind Varma - Designated Partner
- Rohit Kumar Killa - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Fortis Therapeutics is ACF-3008. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Fortis Therapeutics was incorporated on 03 February 2024, making it 2+ years old. It is registered with the Registrar of Companies, Guwahati.
Arvind Varma was appointed as Designated Partner on 08 May 2025. Arvind Varma ceased to be Partner on 07 May 2025. Rohit Kumar Killa was appointed as Designated Partner on 03 Feb 2024.
The registered office of Fortis Therapeutics is at CO Mridu Paban Mahanta J. Das Line Jogesh Das Path Khaliamari, Dibrugarh, Assam, India – 786001.
The total obligation of contribution is ₹60,000.
Fortis Therapeutics has open charges of ₹35 Lakh and no satisfied charges on record as per latest MCA filings.
Fortis Therapeutics can be reached at its registered office: CO Mridu Paban Mahanta J. Das Line Jogesh Das Path Khaliamari, Dibrugarh, Assam, India – 786001.
Fortis Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Guwahati.